Tag: pharma QA

Addressing Tube Leakage Issues in Cream Manufacturing: An Investigation Approach Tube leakage complaints in cream manufacturing can significantly impact product quality, patient satisfaction, and regulatory compliance. When a packaging component…

Addressing Assay Out-of-Specification Results During Bulk Hold: A Comprehensive Investigation Approach Out-of-Specification (OOS) results for assays, particularly during bulk hold phases, can pose significant challenges in pharmaceutical manufacturing. Such occurrences…

Investigation of pH Drift During Method Transfer: Addressing Complaints and Implementing Risk-Based Actions pH drift during method transfer can significantly impact the quality and efficacy of pharmaceutical products, particularly in…

Investigating Tube Leakage Complaints Following Excipient Changes in Pharmaceutical Manufacturing In the pharmaceutical industry, changes in excipients can lead to unforeseen packaging issues, notably tube leakage. Such situations can compromise…

Addressing Emulsion Inversion during Bulk Hold: Key Investigation Strategies In the realm of pharmaceutical manufacturing, emulsion inversion during bulk hold can pose significant challenges. It not only threatens product integrity…

Investigation of Assay OOS Following Excipient Change: Justifying Packaging Compatibility and Stability In pharmaceutical manufacturing, the occurrence of an out-of-specification (OOS) result can trigger complex investigations involving a multitude of…

Investigation and CAPA Approach for Assay OOS during Bulk Hold In pharmaceutical manufacturing, deviation reports relating to Out of Specification (OOS) assays during bulk holds can present significant challenges that…

Investigation of Cleaning Validation Failures After Excipient Changes in Pharmaceutical Manufacturing In the pharmaceutical manufacturing environment, ensuring compliance with Good Manufacturing Practices (GMP) is paramount, particularly when making changes in…